About GlobalData

GlobalData

GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques together, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge.

GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the Oil & Gas, Power, Alternative Energy, Clean Technology, Nuclear Power, Petrochemicals, Mining, Medical Device and Healthcare industries




  • Sweden Renewable Power Market Analysis and Forecasts to 2015


    $2,500
    2010-04-12 00:00:00 | Published by: GlobalData

    Sweden Renewable Power Market Analysis and Forecasts to 2015 Summary GlobalDatas Sweden Renewable Energy Market Analysis and Forecasts to 2015 report provides detailed analysis and forecasts of the Sweden Renewable Energy industry. Sub-chapters in the report analyses each renewable technology in d

  • Brazil's Subsalt Discoveries - Offshore Brazil Emerges as a Leading Investment Destination for Global Oil and Gas Companies


    $3,500
    2010-03-31 00:00:00 | Published by: GlobalData

    Brazil's Subsalt Discoveries - Offshore Brazil Emerges as a Leading Investment Destination for Global Oil and Gas Companies Summary GlobalDatas report Brazil's Subsalt Discoveries - Offshore Brazil Emerges as a Leading Investment Destination for Global Oil and Gas Companies analyzes subsalt discov

  • Belgium Power Market Outlook to 2020


    $1,500
    2010-04-12 00:00:00 | Published by: GlobalData

    Belgium Power Market Outlook to 2020 Summary GlobalData's "Belgium Power Market Outlook to 2020", report gives detailed information on the Belgium power market and provides historical and forecast numbers for generation, capacity and consumption up to 2020. The research analyzes upcoming power pro

  • PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding


    $$2,995
    2014-03-12 00:00:00 | Published by: GlobalData

    PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding Summary GlobalDatas "PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding" report provides in-depth analysis of the current

  • OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018


    $$5,995
    2014-03-12 00:00:00 | Published by: GlobalData

    OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Summary Autism Spectrum Disorders (ASD) is a chronically underserved market currently dominated by the two approved drugs, both of which are antipsychotics. There is off-label use of a multitude of other dru

  • Q4 2013 Global Wind Market Update: Sudden Surge in Q4 Order Intake


    $$500
    2014-02-28 00:00:00 | Published by: GlobalData

    Q4 2013 Global Wind Market Update: Sudden Surge in Q4 Order Intake Summary Global wind market grew drastically in Q4 2013, with firm order intake of 7.0 GW. The US was major country to contribute in this success with a share of 46.4% in Q4 new order intake, whereas the country accounted for 32.6%

  • 2013 Global Solar Market - China Leads by a Landslide


    $$500
    2014-02-28 00:00:00 | Published by: GlobalData

    2013 Global Solar Market - China Leads by a Landslide Summary The global solar Photovoltaic (PV) market increased in capacity by around 37 GW between 2012 and 2013, led by China with 13.4 GW alone. The boom in solar PV installations in the country in 2013, especially in H2, was the outcome of the

  • Upstream Oil and Gas Quarterly Deals Review, Q4 2013 - Similar Deal Activity among Corporate M&As and Capital Markets


    $$1,500
    2014-03-12 00:00:00 | Published by: GlobalData

    Upstream Oil and Gas Quarterly Deals Review, Q4 2013 - Similar Deal Activity among Corporate M&As and Capital Markets Summary GlobalData's Upstream Oil and Gas Quarterly Deals Review, Q4 2013 - Similar Deal Activity among Corporate M&As and Capital Markets report is an essential source of data and

  • LNG Industry Outlook in Europe, 2014 - Capacity Analysis, Forecasts and Details of All Operating and Planned LNG Terminals


    $$5,000
    2014-03-12 00:00:00 | Published by: GlobalData

    LNG Industry Outlook in Europe, 2014 - Capacity Analysis, Forecasts and Details of All Operating and Planned LNG Terminals Summary GlobalDatas energy offering, LNG Industry Outlook in Europe, 2014 - Capacity Analysis, Forecasts and Details of All Operating and Planned LNG Terminals is the essentia

  • LNG Industry Outlook in South and Central America, 2014 - Capacity Analysis, Forecasts and Details of All Operating and Planned LNG Terminals


    $$5,000
    2014-03-12 00:00:00 | Published by: GlobalData

    LNG Industry Outlook in South and Central America, 2014 - Capacity Analysis, Forecasts and Details of All Operating and Planned LNG Terminals Summary GlobalDatas energy offering, LNG Industry Outlook in South and Central America, 2014 - Capacity Analysis, Forecasts and Details of All Operating and

  • Cimzia (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Cimzia (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as the

  • Entyvio (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Entyvio (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as th

  • Humira (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Humira (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as the

  • Prochymal (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Prochymal (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as

  • Remicade (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Remicade (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as t

  • Stelara (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Stelara (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as th

  • Tysabri (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Tysabri (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as th

  • Vercirnon (Crohns Disease) - Forecast and Market Analysis to 2022


    $$3,495
    2014-01-31 00:00:00 | Published by: GlobalData

    Vercirnon (Crohns Disease) - Forecast and Market Analysis to 2022 Summary The Crohns disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as

  • Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: GlobalData

    Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014" provides data on the Age Related Macular Degeneration clinical trial scenario. This report provides element

  • Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: GlobalData

    Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Cutaneous T-Cell Lymphoma clinical trial scenario. This report provides elemental information and da



 1 2 3 >  Last ›